Alternative content

Get Adobe Flash player

eCongress Highlights

The Science of Enbrel
Brings the unique MOA of Enbrel
to life in 3D

For You and Your Patients
Offers you educational tools and
patient materials

Clinical Observations
Features important clinical data
across rheumatology indications

Login to the eCongressRegister now

Welcome to Enbrel.eu

Enbrel* (etanercept) was first approved by the European Commission in 2000.

This site is intended to help Health Care Professionals source additional information on Enbrel*. Either visit the resources available on this site or visit the appropriate country site for information.

Introduction to Enbrel eCongress

The ENBREL eCongress is a unique, highly interactive experience that puts a world of helpful information about ENBREL right at your fingertips. You will have access to a variety of information about the use of ENBREL across its indications.

For localized ENBREL* information please choose country

 

*Enbrel is a registered trade mark of Wyeth

Wyeth is now a part of Pfizer Inc. The merger of local Wyeth and Pfizer entities may be pending in various jurisdictions and is subject to completion of various local legal and regulatory obligations. To learn more, please visit www.pfizer.com.